Digbi Health's Gut Biome and DNA-Based Weight Loss and Diabetes Management Program Launches With a Large California Health Plan
Access to personalized, clinically validated digital therapeutics for obesity and diabetes, delivered through the health plan's Solera-powered wellness navigation platform.
MOUNTAIN VIEW, Calif., November 25, 2019 /Digbi Newswire/ -- Digbi Health's clinically validated, personalized obesity, pre-diabetes and type 2 diabetes management program — tailored to a person's DNA, gut biome, lifestyle preferences and ethnicity — is now available to eligible members on a large California health plan's wellness navigation platform.
The platform, created in collaboration with Solera Health, is a digital therapeutics and community health network. Digbi Health's availability gives members access to a DNA and gut microbiome-based precision care and lifestyle medicine tool tailored to their biology and lifestyle.
Why one-size-fits-all programs fail
Doctors and payers understand that obesity and diabetes are multifactorial diseases, and one-size-fits-all diet and exercise weight loss and diabetes programs do not deliver patient engagement and sustained health results. We are the first company to operationalize a DNA and gut microbiome-based prescription-grade platform for doctors and payers to deliver weight loss and diabetes programs at scale.
— Ranjan Sinha, CEO and Founder, Digbi Health
Digbi Health is a strong fit for their wellness platform, which is designed to drive sustained engagement and outcomes by matching members to the program that best meets their needs.
— Brenda Schmidt, CEO, Solera Health
Platform reach
The health plan, which serves 4.3 million members, launched the platform in June. Powered by Solera, it features approximately 70 digital health apps selected for clinical effectiveness and consumer preference from more than 300,000 available in the Apple App Store.
Originally distributed via PR Newswire.
About Digbi Health
Digbi Health is the precision biology care company unifying metabolic and inflammatory care — including obesity, cardiometabolic, gastrointestinal, and inflammatory disorders. These illnesses share a root cause: a mismatch between an individual's biology and the one-size-fits-all lifestyle guidance they've been given. Digbi combines the gut microbiome, genetics, advanced blood biomarkers, and continuous digital health data to build a unique biological profile for each individual and identify what is driving their disease. AI then personalizes lifestyle treatment and, when needed, clinical treatment, delivered through the first precision-biology AI-orchestrated national telehealth platform. Through Digbi Labs, we invest in our vision of making chronic illness optional and advancing healthspan — partnering with leading universities, pharmaceutical companies, and scientific and clinical laboratories, running distributed human trials and publishing peer-reviewed research on genetics, the gut microbiome, and the use of AI to deliver care that is safe, cost-effective, and accessible. Digbi's healthcare cost reduction is documented in multiple peer-reviewed actuarial claims studies. Digbi is accessible to 30 million individuals through more than 300 employers and health plans.
SOURCE Digbi Health
- Health Plan
- Obesity
- Type 2 Diabetes
- Digital Therapeutics
- Solera Health